Edition:
United States

Bio Rad Laboratories Inc (BIO)

BIO on New York Consolidated

142.99USD
22 Jul 2016
Change (% chg)

$-0.52 (-0.36%)
Prev Close
$143.51
Open
$143.76
Day's High
$144.11
Day's Low
$142.41
Volume
103,486
Avg. Vol
115,423
52-wk High
$152.32
52-wk Low
$122.03

Summary

Name Age Since Current Position

Norman Schwartz

70 2012 Chairman of the Board, President, Chief Executive Officer

Christine Tsingos

57 2012 Chief Financial Officer, Executive Vice President

John Goetz

66 2014 Chief Operating Officer, Executive Vice President

Michael Crowley

54 2014 Executive Vice President, Global Commercial Operations

Shannon Hall

46 2014 Executive Vice President, President, Life Science Group

John Hertia

60 2014 Executive Vice President, President, Clinical Diagnostics Group

Giovanni Magni

59 2014 Executive Vice President, Chief Strategy Officer

Ronald Hutton

58 2012 Vice President, Treasurer

Alice Schwartz

89 1967 Director

Louis Drapeau

72 2007 Independent Director

Robert Malchione

58 2014 Independent Director

Joel McComb

51 2014 Independent Director

Deborah Neff

63 2011 Independent Director

Biographies

Name Description

Norman Schwartz

Mr. Norman D. Schwartz is Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Schwartz has been our President and Chief Executive Officer since 2003 and our Chairman of the Board since 2012. He was our Vice President from 1989 to 2002, our Group Manager, Life Science, from 1997 to 2002 and our Group Manager, Clinical Diagnostics, from 1993 to 1997. We believe Mr. Schwartz’s financial and business expertise gained through over 40 years of service with our Company, including as our President and Chief Executive Officer for over 13 years, give him the qualifications and skills to serve as a director.

Christine Tsingos

Ms. Christine A. Tsingos is Chief Financial Officer, Executive Vice President of the Company. She was the Chief Operating Officer and Chief Financial Officer at Attest Systems, Inc., a provider of information technology asset discovery and management tools, from August 2002 to November 2002. Prior to that, Ms. Tsingos was a consultant to Attest Systems, Inc. from 2000 to 2002. She was the Chief Financial Officer at Tavolo, Inc., an online retailer of gourmet cookware and food, from 1999 to 2000, and she was Treasurer, and later Vice President and Treasurer, of Autodesk, Inc., a developer of design software, from 1990 to 1999.

John Goetz

Mr. John Goetz is Chief Operating Officer, Executive Vice President of the Company. He was appointed Executive Vice President and President of the Clinical Diagnostics Group in 2012 and was Vice President and Group Manager of the Clinical Diagnostics Group from 2000 to 2012. Previously, he held various positions within Bio-Rad since joining us in 1974 including Plant Engineer, Manufacturing Manager, Division Manager, Quality Systems Division and Operations Manager of the Diagnostics Group.

Michael Crowley

Mr. Michael Crowley is Executive Vice President, Global Commercial Operations of the Company. He was Vice President, Commercial Manager, Europe from 2012 to 2014 and Commercial Manager, Clinical Diagnostics Group, Europe from 2011 to 2012 and Division Manager of the Clinical Diagnostics Group North American Sales Organization from 2008 to 2011. Prior to that, he was the Clinical Diagnostics U.S. National Sales Manager since joining Bio-Rad in 1998.

Shannon Hall

Ms. Shannon Hall is Executive Vice President, President, Life Science Group of the Company. She was Vice President and General Manager of the Laboratory Separations Division, Life Science Group from 2008 to 2014. Prior to that, she held various positions within our Life Science Group since joining Bio-Rad in 1992, including Division Marketing Manager of each of the Laboratory Separations Division and Gene Expression Division, Business Unit Marketing Manager of the Molecular Biology Business Unit, as well as several product manager positions.

John Hertia

Mr. John Hertia is Executive Vice President and President, Clinical Diagnostics Group of the Company. He was Senior Vice President of Global Technology and Systems from 2010 to 2014, Worldwide Group Operations Manager, Life Science Group from 2006 to 2010 and Operations Manager Clinical Diagnostics Group, U.S. Operations from 2000 to 2006. Prior to that, he held various positions within our Clinical Diagnostics Group since joining Bio-Rad in 1982, including Business Development and Strategic Marketing Manager and North American Sales Division Marketing Manager.

Giovanni Magni

Mr. Giovanni Magni is Executive Vice President, Chief Strategy Officer in August 2014 of the Company. He was Executive Vice President of International Sales from 2012 to 2014 and Vice President and International Sales Manager from 2004 to 2012. Prior to that, he held various positions within Bio-Rad since joining us in 1995, including Diagnostic Division Manager, Southern Europe and Diagnostics Group Operation Manager, France.

Ronald Hutton

Mr. Ronald W. Hutton is Vice President, Treasurer of the Company. He has been Treasurer since 1997 and was appointed Vice President in 2012. Previously, he was Director of Treasury at Kaiser Aluminum & Chemical Corporation from 1993 to 1997.

Alice Schwartz

Mrs. Alice N. Schwartz is Director of the Company. She was a Research Associate at the University of California. As a co-founder of our Company, Mrs. Schwartz has a unique and invaluable understanding of our Company’s business practices and core values. We believe that Mrs. Schwartz’s technical and business expertise gained through her many years as a researcher and as a director of our Company give her the qualifications and skills to serve as a director.

Louis Drapeau

Mr. Louis C. Drapeau is an Independent Director of the Company. He was Vice President and Chief Financial Officer of InSite Vision and was Chief Executive Officer of InSite Vision from 2008 to 2010. From 2006 to 2007, he was Senior Vice President and Chief Financial Officer of Nektar Therapeutics. From 2004 to 2005 he was Acting Chief Executive Officer, and from 2002 to 2005 Senior Vice President and Chief Financial Officer, of BioMarin Pharmaceutical. From 1971 to 2002 he was with Arthur Andersen, where he was a Partner from 1983 to 2002 and Managing Partner from 1985 to 1997. He is also a Board member of AmpliPhi Biosciences Corp., and of Avita Medical Ltd. He was a Board member of Inflazyme Pharmaceuticals Ltd. from 2006 to 2008, Bionovo, Inc. from 2007 to 2012 and Intermune, Inc. from 2007 to 2014. We believe that Mr. Drapeau’s financial and business expertise gained through his many years as an accountant, executive and director of various public companies give him the qualifications and skills to serve as a director.

Robert Malchione

Mr. Robert M. Malchione is Independent Director of the Company. He held multiple positions at Avery Dennison Corporation, the last of which was Senior Vice President, Corporate Strategy and Technology. From 1983 to 2000, he held multiple positions at Boston Consulting Group, the last of which was Officer, Director and Partner. We believe that Mr. Malchione’s strategic and operational expertise gained through his many years working with large, global organizations give him the qualifications and skills to serve as a director.

Joel McComb

Mr. Joel McComb is Independent Director of the Company. He is currently Chief Executive Officer. In 2010 he was Chief Operating Officer of Synthetic Genomics Inc., and from 2008 to 2010, he was Senior Vice President and General Manager of Illumina, Inc.’s Life Science Business Unit. From 2004 through 2008 he worked at General Electric, serving as President, GE Healthcare Life Sciences-Discovery Systems, and later as President, GE Healthcare, Interventional Medicine. From 2001 through 2004 he was President and Chief Executive Officer of Innovadyne Technologies, Inc. Prior to this, he held a series of executive, product development, business and sales positions at Beckman Coulter, Inc. We believe that Mr. McComb’s broad experience for over 25 years in the life science and diagnostics business gives him the qualifications and skills to serve as a director.

Deborah Neff

Ms. Deborah J. Neff is Independent Director of the Company.She was Chief Operating Officer at Complete Genomics Inc., a life science company in genome sequencing. In 2013 she was an executive advisor in the health care industry. From 2006 to 2012, she was President, and Chief Executive Officer of Pathwork Diagnostics, Inc. From 2003 to 2006, she was the Chief Executive Officer of Predicant Biosciences. From 1988 to 2003, she served in various positions at BD Biosciences, including as worldwide President from 1995 to 2003. We believe that Ms. Neff’s management experience in the healthcare and life sciences industries for over 25 years gives her the qualifications and skills to serve as a director.

Basic Compensation

Options Compensation